Randomized Trialhigh evidence
Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.
The New England journal of medicine·November 13, 2025·PMID 40888702
Why it mattersCurrent beta-blocker recommendations post-MI with preserved EF rely on older trials predating modern reperfusion and pharmacotherapy. This large, contemporary trial provides high-quality evidence that routine beta-blocker use may not improve outcomes in this population, potentially simplifying post-MI regimens.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled